avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nanog
|
ENSMUSG00000012396.6 | Nanog homeobox |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nanog | mm10_v2_chr6_+_122707489_122707608 | 0.17 | 3.2e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.5 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) neuron projection maintenance(GO:1990535) |
2.1 | 8.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.9 | 5.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.6 | 4.9 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.9 | 9.3 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.9 | 13.5 | GO:0015816 | glycine transport(GO:0015816) |
0.8 | 6.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 0.7 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.7 | 2.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 2.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.6 | 1.9 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.6 | 10.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 1.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.6 | 2.4 | GO:0015824 | proline transport(GO:0015824) L-serine transport(GO:0015825) |
0.6 | 1.2 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.6 | 3.6 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.5 | 2.2 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.5 | 5.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.5 | 3.6 | GO:0035989 | tendon development(GO:0035989) |
0.5 | 2.0 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 1.3 | GO:0071661 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.4 | 3.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 2.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 1.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 2.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 0.6 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.3 | 0.9 | GO:1901355 | response to rapamycin(GO:1901355) |
0.3 | 2.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.3 | 0.9 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.3 | 3.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.2 | 2.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 2.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.6 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.2 | 0.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 28.2 | GO:0007586 | digestion(GO:0007586) |
0.2 | 0.8 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.2 | 1.1 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.2 | 2.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 1.3 | GO:0044838 | cell quiescence(GO:0044838) regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 4.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 1.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 5.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 1.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 2.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 1.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.3 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 0.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.5 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 2.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 2.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 2.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 1.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 1.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.9 | GO:0045835 | brain renin-angiotensin system(GO:0002035) negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.6 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.0 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.1 | 3.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 1.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 1.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 1.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.4 | GO:0006363 | transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 2.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 1.9 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 2.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.5 | GO:0072658 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 1.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 2.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 2.4 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 2.9 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 1.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.0 | 0.1 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) |
0.0 | 1.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 1.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 1.2 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.8 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.2 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 1.9 | GO:0071773 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.0 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) uterus morphogenesis(GO:0061038) |
0.0 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 1.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 8.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 3.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 2.9 | GO:0000801 | central element(GO:0000801) |
0.3 | 2.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.3 | 3.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 0.8 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 2.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.9 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 0.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 2.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.1 | 0.7 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 1.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.4 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 2.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.4 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 1.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 4.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 2.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 3.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 3.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 4.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 2.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 38.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 4.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 2.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 3.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 6.4 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.9 | GO:0031672 | A band(GO:0031672) |
0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 2.1 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 5.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 13.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.1 | 11.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.0 | 11.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.8 | 5.8 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.6 | 3.6 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.5 | 3.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.5 | 3.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 1.9 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.5 | 1.4 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 1.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 3.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.4 | 2.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 2.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.1 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.3 | 5.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.3 | 0.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 0.8 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.2 | 0.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 4.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.7 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.2 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.6 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.2 | 1.0 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 2.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 4.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 6.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 3.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.2 | 1.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 1.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 31.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 2.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 2.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 0.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 2.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.2 | GO:0019841 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.1 | 1.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 3.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 1.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 2.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 1.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 3.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 1.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0052740 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 3.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 5.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 1.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 8.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 1.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 2.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 12.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 8.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 6.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 5.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 5.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.0 | PID ATM PATHWAY | ATM pathway |
0.0 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 2.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 7.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 2.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.1 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 11.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 15.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 16.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 4.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 6.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 6.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 1.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 3.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 2.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 9.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 5.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 7.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 2.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 2.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 1.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 2.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 3.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |